Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Paul Bisaro
AddedMar 31, 2024
UpdatedMay 1, 2026
Paul Bisaro

Paul Bisaro

Board Member, Myriad Genetics

Paul Bisaro's Career

Myriad Genetics
Myriad Genetics

Salt Lake City, UT, US

Board Member· Board
Zoetis
Zoetis

Parsippany-Troy Hills, NJ, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Paul Bisaro's Career

Myriad Genetics
Myriad Genetics
Public$90M2.6k1991Salt Lake City, UT, US
Board Member· Board

Leadership at Myriad Genetics

Walter GilbertWalter GilbertFounder
Rashmi KumarRashmi KumarBoard Member
Heiner DreismannHeiner DreismannBoard Member
Paul DiazPaul DiazCEO
Dan SpiegelmanDan SpiegelmanBoard Member
Louise PhanstielLouise PhanstielBoard Member

Similar to Myriad Genetics

InvitaeInvitaeSan Francisco, CA, USGenetic Testingest. 2010InvitaeSan Francisco, CA, US · est. 2010

Invitae Corp., a global genetic information company, specializes in diagnostics, oncology, pediatrics, and hereditary screening.

Public · $2.5B1.7k
23andMe23andMeSunnyvale, CA, USGenetic Testingest. 200623andMeSunnyvale, CA, US · est. 2006

23andMe: A biotech firm offering direct-to-consumer genetic testing for ancestry and health predispositions.

Public · $1.1B816
GeneDx HoldingsGeneDx HoldingsStamford, CT, USGenetic Testingest. 2017GeneDx HoldingsStamford, CT, US · est. 2017

Connecticut-based GeneDx, a software company merging diagnostics and data science for personalized health insights.

Public · $941M919
Foundation MedicineFoundation MedicineCambridge, MA, USCancer Diagnosticsest. 2010Foundation MedicineCambridge, MA, US · est. 2010

Foundation Medicine, Inc.: A U.S. genomics firm specializing in personalized cancer diagnostic technology.

Public · $96.5M662
Zoetis
Zoetis
Public$27.3M1.4k1952Parsippany-Troy Hills, NJ, US
Board Member· Board

Leadership at Zoetis

Chaithanya YambariChaithanya YambariCo-Founder & CTO
Ritish ReddyRitish ReddyCo-Founder & CEO
Sethu MeenakshisundaramSethu MeenakshisundaramCo-Founder
Michael McCallisterMichael McCallisterBoard Member
Kristin PeckKristin PeckCEO
Louise M ParentLouise M ParentBoard Member

Similar to Zoetis

SpendfloSpendfloSan Francisco, CA, USSaaS Managementest. 2020SpendfloSan Francisco, CA, US · est. 2020

A suite of tools for organizations to buy, negotiate, renew and track their SaaS subscriptions.

Series A · $15.4M137
ZyloZyloIndianapolis, IN, USSaaS Managementest. 2016ZyloIndianapolis, IN, US · est. 2016

A SaaS management platform (SMP) that optimizes cloud-based tech stack orchestration.

Series C · $71.8M155
TropicTropicNew York City, NY, USSaaS Procurementest. 2019TropicNew York City, NY, US · est. 2019

A SaaS management platform (SMP) that offers full-service procurement solutions.

Series B · $67.1M408
ToriiToriiBoston, MA, USReal Estate, SaaSest. 2017ToriiBoston, MA, US · est. 2017

Enterprise-grade tools to discover, optimize, and control SaaS usage and cost.

Series B · $69.6M17

Paul Bisaro's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Paul Bisaro

Dr. Giovanni CaforioDr. Giovanni CaforioBoard Member · Bristol Myers SquibbPaul S. HerendeenPaul S. HerendeenBoard Member · Elanco Animal HealthRonald GoldRonald GoldBoard Member · NJ BioDavid BrownDavid BrownBoard Member · ActivzDaniel AdamsDaniel AdamsBoard Member · NextWaveBioGeorge ScangosGeorge ScangosBoard Member · Agilent Technologies